1. Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma—a mini-review
   Shruti Gupta et al, 2021, Molecular Biology Reports CrossRef
2. Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo
   Venugopal R. Bovilla et al, 2021, Biomedicines CrossRef
3. Itraconazole Inhibits the Growth of Cutaneous Squamous Cell Carcinoma by Targeting HMGCS1/ACSL4 Axis
   Congcong Xu et al, 2022, Frontiers in Pharmacology CrossRef
4. Diagnostic model constructed by five EMT-related genes for renal fibrosis and reflecting the condition of immune-related cells
   Yangyang Guo et al, 2023, Frontiers in Immunology CrossRef
5. Current trends and future prospects of drug repositioning in gastrointestinal oncology
   Nayeralsadat Fatemi et al, 2024, Frontiers in Pharmacology CrossRef
6. Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
   Nnenna Elebo et al, 2023, Frontiers in Genetics CrossRef
7. A Review of the Mechanisms of Wnt7b in the Process of Malignant Tumor Invasion and Metastasis
   Tengjiao Song et al, 2019, International Journal of Pharmacology CrossRef
8. Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma
   Zedan Zhang et al, 2022, Journal of Immunology Research CrossRef
9. SNORA38B promotes proliferation, migration, invasion and epithelial-mesenchymal transition of gallbladder cancer cells via activating TGF-β/Smad2/3 signaling
   Yiyu Qin et al, 2023, European Journal of Histochemistry CrossRef